Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orion Corp.

www.orion.fi

Latest From Integra LifeSciences

M&A Analysis: April Showers Big Name Acquisitions

M&A deals rained down in April with the highest number of acquisitions of the year to date. The month saw 14 M&A deals, up by four from March's total, but still down from the 16 deals recorded in April 2016.

M & A Deals

Integra Thinks High Margin, Differentiated Portfolio Can Deliver A Transformative 2017

Integra LifeSciences surged to industry-leading 12% sales growth in 2016, and that's before it prepares to consolidate two of the biggest acquisitions in its history. What is the strategy behind the success of the specialty surgery, orthopedics and tissue tech company that is looking at another double-digit sales uplift in 2017?

Orthopedics Wound Healing & Tissue Repair

M&A Deals Analysis: February Sees Billion-Dollar Buys Bite

Despite being a slow month, megadeals abounded in February, as the medtech M&A market saw a hat-trick of billion-dollar deals. Medtech Insight recorded 12 deals for the month, on par with January's volume but down from 16 in February 2016.

M & A Deals

Integra Aims To Bolster Neurology Portfolio With J&J Codman Buy

Only a month after buying the tissue regeneration company Derma Sciences, Integra has announced a much larger acquisition for Codman Neurosurgery. The company says the buy would complement its current neurosurgery portfolio and boost its global reach.

Neurology Deals
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Finland
  • Parent & Subsidiaries
  • Orion Corp.
  • Senior Management
  • Timo Lappalainen , Pres., CEO & Chmn.
    Jari Karlson, CFO
    Satu Ahomaki, SVP, Global Sales
    Reijo Salonen, MD, PhD, SVP, Pharma R&D & CMO
  • Contact Info
  • Orion Corp.
    Phone: (358) 10 4261
    Orionintie 1A 02200
    P.O. Box 65 Espoo, 02101
    Finland
Advertisement
Advertisement
UsernamePublicRestriction

Register